but not in patients. Indeed, to our knowledge, only one study specifically evaluated the reproducibility of GE measured with scintigraphy in patients, ie, in type 1 diabetes. 5 Our aims were to evaluate the day-to-day reproducibility of GE assessed by scintigraphy in patients with normal, delayed, and rapid GE.
| MATERIAL S AND ME THODS

| Participants
All subjects gave their written informed consent to participate in the protocol, which had been approved previously by the Institutional Review Board and Radiation Safety Committee of the Mayo Clinic.
Among 60 patients (38 females, median age 48 years, range 18-84 years, BMI 26.81 ± 0.85 kg/m 2 [mean ± SEM]) with upper gastrointestinal symptoms who underwent a clinically indicated assessment of GE with scintigraphy, symptoms and GE were re-evaluated with scintigraphy 15 ± 1 days after the first GE assessment. There was no change in treatment between the first and second GE studies. The exclusion criteria included severe nausea or vomiting, which may preclude study assessments, medications (eg, narcotics, medications with significant anticholinergic effects, glucagon like peptide-1 (GLP-1) agonists, or prokinetic agents) that were not discontinued within 4 half-lives prior to scintigraphy, clinical evidence of severe systemic diseases that may interfere with the objectives of the study, prior gastric or major intestinal (ie, resection of >50 cm) or colonic surgery (ie, hemi or subtotal colectomy), allergy to eggs or reluctance to consume milk, and abdominal radiation therapy.
| Assessments
Before the GE study, gastrointestinal symptoms were evaluated with symptom questionnaires based on the Rome III symptom criteria 6,7 the Gastrointestinal Cardinal Symptom Index (GCSI), which inquires about upper GI symptoms over the past 2 weeks, 8 Patient
Assessment of Upper Gastrointestinal Disorders-Symptom Severity (PAGI-SYM) index, 9 and the Hospital Anxiety and Depression
Questionnaire. 10 Females of child-bearing potential underwent a pregnancy test within 48 hours of each study.
| GE study
After an overnight fast, subjects ingested a 99mTc-labeled meal consisting of two scrambled eggs, one slice of whole wheat bread, and one glass of skim milk. 4 Abdominal images of 2 minute duration were acquired with anterior and posterior gamma cameras immediately following ingestion of the radiolabeled meal and at specified time points during the subsequent 4 hours period, typically every 15 minutes during the first 2 hours and every 30 minutes during the subsequent 2 hours. GE was defined as normal, rapid, and delayed using data (5th to 95th percentile values) in 319 healthy people. 4 In females, the normal range for GE is 4%-31% at 1 hour, 25%-71% at 2 hours and 76%-100% at 4 hours. In males, the corresponding values are 5%-40% at 1 hour, 28%-82% at 2 hours and 77%-100% at 4 hours. Patients in whom emptying was less than these values at 2 or 4 hours were characterized as delayed. Conversely, patients in whom emptying was greater than these values at 1 or 2 hours were characterized as rapid.
| Statistical analysis
The concordance between GE measurements on two separate days was assessed by Lin's concordance statistic (the concordance correlation coefficient [CCC]). 11 The paired t-test was used to compare within subject differences against zero. A Bland-Altman assessment examined whether the magnitude of differences between two measurements was correlated with the magnitude of the measured responses (ie, the average value for both studies) using Pearson's correlation coefficient. 12 The inter-individual coefficient of variation (COV) was the SD divided by the mean, expressed as a percentage. 4 The intra-individual COV 2 (%) for each participant was calculated by the formula [((Difference between 1st and 2nd studies) 2 /2)/(Average of 1st and 2nd studies) 2 ] × 100.
This parameter was averaged across all participants; the square root of this average, expressed as a percentage provided the intraindividual COV. 13 
| RE SULTS
| Demographics and associated conditions
The age, gender, and BMI were not significantly different among patients with normal, rapid, and delayed GE ( 
Key Points
• Assessments of gastric emptying measured with scintigraphy are relatively reproducible in patients with upper gastrointestinal symptoms.
• The inter-individual coefficient of variation for gastric emptying t 1/2 (40%) was greater than the intra-individual COV (20%).
• In 30% of patients, the characterization of gastric emptying as normal, delayed, and rapid differed between the two studies.
| Diabetes mellitus
Among 21 diabetics, 6 had type 1 DM; one also had celiac disease. The duration of DM was 14 ± 2 years and the mean glycosylated hemoglobin (HbA1c) was 7.6 ± 0.3%. The fasting blood sugar level in diabetics was 149 ± 12 mg/dl before the first study and 168 ± 19 mg/dl before the second study. Three patients had significant hyperglycemia (>275 mg/dl) before one of the scans.
Two of these had delayed and 1 had rapid emptying. Fifteen DM patients had complications including peripheral and/or autonomic neuropathy (eight patients), retinopathy (four patients), and nephropathy (five patients). Among diabetics, nine were treated oral hypoglycemic agents, 11 with insulin, and one with a combination of these agents. with unexplained weight loss, had a symptom score <2.5 on the PAGI questionnaire. Forty-six patients also had functional lower GI symptoms. Many patients had overlapping symptoms (not shown).
| Gastrointestinal symptoms
Among 55 patients who returned the GI symptom questionnaires, the mean GCSI total score was 1.47 ± 0.1 and the mean FDA composite score was 2.3 ± 0.1. Fifteen and 15 patients had significant anxiety and depression as evidenced by HAD scores ≥11
respectively.
| Intra-individual reproducibility
Among 60 patients, 25 had normal, 18 had rapid, and 17 had delayed GE during the first study. During the second study, 37 had normal, 11 had rapid, and 12 had delayed GE. In 28 of 29 studies with delayed GE, the diagnosis of delayed GE was based on delayed GE at 4 hours. The remaining patient had delayed GE at 2 hours only. In the first study, 17 participants had delayed GE, of which nine had delayed GE at 4 hours only, seven had delayed GE at 2 and 4 hours, and only one had delayed GE at 2 hours only. Of the 12 participants with delayed GE in the second study, nine had delayed GE at 4 hours only and three had delayed GE at both 2 and 4 hours.
Twenty four of 29 rapid GE studies were diagnosed by rapid GE at 1 hour, with or without rapid GE at 2 hours. Only 5 of 29 studies with rapid GE were diagnosed based on rapid GE at 2 hours only. In the second GE study in these patients, all 5 patients satisfied criteria for rapid GE at 1 and 2 hours (4 patients) or at 1 hour alone (1 patient).
The average absolute difference in GE between the two studies was 7% at 1, 9% at 2, and 7% at 4 hours and 25 minutes for GE t 1/2 .
This difference was not different among patients with normal, rapid, and delayed emptying. Overall, GE measurements at 1 hour (CCC and to a lesser extent at 4 hours (0.54; 95% CI, 0.34, 0.7) were significantly correlated between the first and second studies. (Table 2 , Figure 1 ) Values for first and second assessments at corresponding time were different (P = .01) at 4 hours but not at 1 or 2 hours. For t 1/2 , but not the other parameters, the Bland-Altman test was significant, ie, differences between the first and second studies were related to the average GE, being greater in patients with delayed GE (Figure 2 ).
The intra-individual COV for GE at 1, 2, 4 hours and the t 1/2 was 28%, 23%, 11%, and 20% respectively (Table 3) . At 1 (P < .0001), 2 TA B L E 1 Demographic and baseline clinical features (P < .0001) and 4 hours (P < .0001); the intra-individual COV was different among patients with normal, delayed and GE (Table 3) .
At 1 hour, the intra-individual COV was 30%, 20% and 34% in patients with normal, rapid, and delayed GE respectively. At 2 hours, this intra-individual COV was greater in patients with delayed (36%) than normal (14%) or rapid GE (14%). Likewise, at 4 hours, the intra-individual COV was greater in patients with delayed (19%) than normal (6%) or rapid (4%) GE.
Among 25 patients with normal GE in the first study, 22 had normal, 1 had rapid, and 2 had delayed GE during the second study. Of 18 patients who had rapid emptying in the first study, 8 had normal and 10 had rapid emptying in the second study. Among the 17 F I G U R E 1 Day-to-day reproducibility of gastric emptying at 1 h (top left), 2 (top right), 4 h (bottom left) and gastric emptying t 1/2 (bottom right). Observe excellent agreement at all time points. Participants in which the overall interpretation (ie, as normal, rapid, or delayed GE) was different between the first and second studies are depicted with filled markers. The range of normal values in the first study are depicted by the rectangular areas outlined by dotted red (in women) and blue lines (in men). During the first study, GE1 was accelerated in 14 participants, GE2 was accelerated in 13 and delayed in eight participants, and GE4 was delayed in 16 participants patients who had delayed emptying during the first study, 7 had normal and 10 had delayed emptying in the repeat study. In no patients did the diagnosis change from delayed to rapid GE or vice versa between the first and second studies.
TA B L E 2 Intra-individual day-to-day reproducibility of gastric emptying measurements with scintigraphy
The intra-individual COV at 1, 2, and 4 hours was, respectively, 29%, 23%, and 12% in non-diabetics and 26%, 23%, and 9% in diabetics. The intra-individual COV for GE t 1/2 in non-diabetics and diabetics, respectively, was 20% and 21%.
| Inter-individual variability
Among all participants, the inter-individual COV was 56% at 1, 43% at 2, and 17% at 4 hours (Table 3 ). For GE t 1/2 , the inter-individual COV was 40%. Similar to the intra-individual COV, the interindividual COV for GE at 1 hour was similar among patients with normal, rapid, and delayed GE. At 2 and 4 hours, the inter-individual COV was greater in patients with delayed than normal or rapid GE. The inter-individual COV for GE at 1, 2, and 4 hours and t 1/2 was, respectively, 59%, 42%, 17%, and 37% in non-diabetics and 52%, 43%, 19%, and 47% in diabetics.
| D ISCUSS I ON
By virtue of the distribution of patients with and without diabetes mellitus, the typical upper gastrointestinal symptoms, and the range of GE disturbances, this cohort is representative of patients seen in clinical practice. Indeed, the initial GE test was performed as part of the clinical assessment. While GE measured with scintigraphy was relatively reproducible over 2 weeks, the characterization of GE as normal, delayed, or rapid was different between the first and second studies in 18 of 60 patients (30%). Among these patients, the characterization switched from normal to rapid or delayed GE, or vice versa, but not from rapid to delayed emptying or vice versa. In part, these differences probably reflect regression to the mean and the limitations of summarizing continuous metrics as dichotomous (ie, normal or abnormal) variables such that relatively small differences in the amount emptied may affect the interpretation of the final result. 14 Four of six patients with <65% emptying at 4 hours also had delayed GE during the second study. Hence, in patients with markedly delayed emptying, a single assessment is probably sufficient. When the delay is less severe, it may be prudent to consider documenting delayed GE on two occasions before assigning the diagnosis of gastroparesis, particularly given the overlap between gastroparesis and dyspepsia with delayed GE.
15,16
The intra-individual variability in GE at 1, 2, and 4 hours and the GE t 1/2 was, respectively, 28%, 23%, 11%, and 20%. Between 1 and 4 hours, the variability declines as more food empties from the stomach, reflecting a ceiling effect. For the GE t 1/2 , the intraindividual COV of 20% is comparable to the corresponding value of 24% in healthy people, 4 29% in 14 patients with DM, 5 and 24% in 10 DM patients randomized to placebo in a randomized controlled trial with relamorelin. 17 These values and all data in this manuscript express GE as the amount emptied. Alternatively, GE can be expressed as the amount retained, for example at 1, 2, and 4 hours. At any time, the values for intra-individual COV expressed as the amount emptied or retained may be different. For example, for a woman in whom emptying at 4 hours is 78% in the first and 98% during the replicate study, the COV is 3%. However, the COV for the amount remaining (ie, 22% during the first and 2% during the second study) is 139%. While the latter value is high, it is noteworthy that GE at 4 hours is normal in both studies.
In this study, the inter-individual COV (40%) was greater than the intra-individual COV (20%) for the GE t 1/2 . In the phase 2 trial of relamorelin for gastroparesis, a 10% reduction in GE measured with the GE breath test was clinically significant. 18 With an interindividual COV of 40%, it is estimated that 231 subjects will be necessary to detect an effect size of 10% between two treatments with 80% power and a 2-sided α level of 0.05. By comparison, among healthy subjects, the inter-and intra-individual reproducibility for scintigraphic t 1/2 were approximately 24%. 4 Similarly, Lartigue et al. 5 observed that the inter-individual COV was greater in diabetics (76%) than healthy people (20%).
The intra-individual COV for GE measured with scintigraphy in this study is lower than that measured with the SmartPill capsule in 10 healthy male subjects, ie, 40% at 2 weeks and 24% at 4 weeks.
19
The intra-individual COV for GE measured with the SmartPill capsule in patients is unknown. The intra-(20%) and inter-individual (40%) COV for GE t 1/2 measured with scintigraphy are greater than corresponding values, respectively, 21% and 15% for MRI measurements of gastric volumes, which are used to calculate GE, in patients with dyspepsia. 20 In summary, GE measured with scintigraphy is relatively reproducible in patients with upper GI symptoms. However, in 30% of patients, the interpretation of GE as normal, rapid, or delayed was different between the studies. For GE t 1/2 , the inter-individual COV (40%) was greater than the intra-individual COV (20%). These observations are useful for estimating the sample size in therapeutic trials that include GE as an endpoint.
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